<DOC>
	<DOCNO>NCT01689311</DOCNO>
	<brief_summary>The purpose study compare ability isolated sample uterine muscle tissue ( tissue bath ) contract presence various drug . The drug study -- uterotonics -- typically use contract uterus pregnant patient continue bleed delivery . Amongst common uterotonic drug , namely oxytocin , ergonovine , prostaglandin F2alpha , misoprostol , effective one use unknown . The investigator test isolated uterine muscle sample increase concentration four drug three patient population : non-laboring , labor without exogenous oxytocin augmentation , labor oxytocin augmentation . Contractile measure measure compare group . The investigator hypothesize oxytocin alone weak uterotonic effect oxytocin-augmented laboring patient , four drug induce different pattern contraction .</brief_summary>
	<brief_title>In Vitro Myometrial Contractions Laboring Non-laboring Women</brief_title>
	<detailed_description>Postpartum hemorrhage ( PPH ) major cause maternal mortality morbidity . In 80 % case PPH , primary cause failure uterus contract delivery baby , require treatment mother uterotonic drug ( drug use contract uterus thus prevent bleed ) . Patients participate study ask donate small sample uterine tissue Cesarean section , test laboratory ability contract response uterotonics oxytocin , ergonovine , prostaglandin F2alpha , misoprostol . We seek good understand effect drug compare contractile capability isolate uterine tissue .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Dinoprost</mesh_term>
	<mesh_term>Dinoprost tromethamine</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Ergonovine</mesh_term>
	<criteria>Gestational age 3741 week Patients require primary first repeat Cesarean section Cesarean section spinal anesthesia Patients require general anesthesia Patient previous myometrial surgery one previous Cesarean section Patients placental anomaly Patients multiple pregnancy ( twin , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Uterine contraction</keyword>
	<keyword>Dose response</keyword>
	<keyword>Non-laboring</keyword>
	<keyword>Laboring</keyword>
	<keyword>Laboring oxytocin augmentation</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Ergonovine</keyword>
	<keyword>Prostaglandin F2alpha</keyword>
	<keyword>Misoprostol</keyword>
</DOC>